INTRODUCTION
Sleepiness is a major cause of vehicular and occupational accidents, resulting in a large societal and economic burden. 1, 2 Insufficient sleep results in a broad range of performance deficits, including decreased vigilance, slower response times, increased errors, and impaired decision making. 3 These performance deficits and the inability to resist falling asleep contribute to automobile crashes and industrial accidents (e.g., the Exxon Valdez oil spill and nuclear accidents in Chernobyl and on Three Mile Island). 4 Sleep loss can result from acute sleep deprivation, daily sleep restriction (e.g., ≤ 6 h of sleep per night), or when sleep is disrupted as part of a sleep disorder. The effects of sleepiness on performance have been compared with the effects of being intoxicated with alcohol. After 24 hours of sustained wakefulness, performance decrements on some tasks are similar to those observed at a blood alcohol concentration of 0.10%, beyond the legal limit for driving. 5 A similar negative impact of sleep loss on performance has been demonstrated when individuals are tested after a week of sleep restriction
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http://dx.doi.org/10.5665/sleep. 1688 Heart Rate Variability Can Be Used to Estimate Sleepiness-related Decrements in Psychomotor Vigilance during Total Sleep Deprivation horizontally at the level of the subjects' eyes was approximately 0.6 lux (range = 0.59 to 0.63 lux; 1.1 to 2.4 μW/cm 2 ). After completing the CR procedure, participants were given a 12-hour sleep opportunity before being discharged from the study. Researchers were present at all times during the 4-day study to carry out research procedures and to ensure protocol compliance.
Subjective Sleepiness and Performance Testing
Every 2 hours during the CR procedure, subjects completed the Karolinska Sleepiness Scale (KSS), 16 which is a 9-point scale for assessing sleepiness with responses ranging from "very alert (1)" to "very sleepy, great effort to keep awake, fighting sleep (9) ." Subjects also completed a visual analogue scale (VAS), 17 which asked participants to rate how they feel on a line labeled with the word pair "sleepy" and "alert" at opposite ends. Sustained visual attention was assessed using a 10-minute PVT. During the PVT, participants were required to maintain their fastest possible reaction time (RT) to a simple visual stimulus with random interstimulus intervals between 2 and 10 seconds. 18 PVT lapses were defined as RTs that exceeded 0.5 seconds. The first test battery was given 4.5 hours after wake time, resulting in a total of 18 PVT test sessions during the CR procedure.
Physiologic Measurements and Signal Processing
The ECG, EEG, and EOG were recorded continuously during the CR procedure. Signals were bandpass-filtered at 0.3 to 35 Hz and recorded at 200 Hz using a Comet Portable EEG system from Grass Technologies (Astro-Med, Inc., West Warwick, RI). Subjects were asked to press an event marker to mark the onset and offset of PVT testing in the EEG recording. Occasionally, participants forgot to press the event marker, in which case a research technician made an annotation manually in the EEG record using a separate event marker. Given that the timing of pressing the event marker did not always coincide exactly with the onset or offset of the PVT, performance and physiologic signals (see below) were assessed during the middle 8 minutes between marked events, to ensure that physiologic data were analyzed only during the PVT.
The ECG
The ECG was recorded with a single-channel modified V5 lead. QRS peaks were detected using a Hilbert transform-based method, 19 and the RR-interval time series was determined. Spectral analysis was performed on each RR-interval series using the Lomb-Scargle periodogram method. 20 We examined conventional HRV spectral analysis metrics defined by the Task Force for Heart Rate Variability Analysis. 21 These metrics include RR-interval spectral power in very-low-frequency (VLF, ≤ 0.04 Hz), low-frequency (LF, 0.04 -0.15 Hz) and high-frequency (HF, 0.15 -0.40 Hz) bands, normalized LF and HF power, and the ratio of LF to HF power. In separate analyses, RR-interval power density was determined in 0.02-Hz bins from 0.0 to 0.4 Hz.
The EEG
The EEG was recorded from the z-line using the International 10-20 System for electrode placement, with frontal (Fz), central (Cz), parietal (Pz) and occipital (Oz) derivations and 2 mastoid references (A1 and A2). Each derivation was averaged online es multiple bio-signals simultaneously may perform better than any one measure taken alone. Here, we examined heart rate variability (HRV) as a potential adjunct to existing measures of sleepiness derived from the eyes, face, and head. As demonstrated by routine clinical use of 24-hour Holter monitoring, electrocardiogram (ECG) signals can be collected continuously in diverse operational settings. In addition, new technologies allow for noncontact recording of heart-beat measurements. 13 Recently, it was shown that some measures of HRV can be used to predict daytime performance levels. 14 In the present study, we extend these findings by examining whether HRV can be used to estimate changes in sustained visual attention during total sleep deprivation. We show that, similar to EEG and PER-CLOS measures, RR-interval power density in the 0.02-to 0.08-Hz frequency range correlates strongly with lapses on the Psychomotor Vigilance Task (PVT) and can be used to estimate decrements in PVT performance caused by sleepiness.
METHODS

Subjects
Young healthy Chinese men (n = 24) (mean age ± SD = 25.9 ± 2.8 years) were enrolled in a 4-day study at the Chronobiology and Sleep Laboratory (CSL), Duke-NUS Graduate Medical School Singapore. Health was assessed by screening questionnaires and self-reported medical history. Participants had an average body-mass index of 22.3 ± 2.7 kg/m 2 and reported no use of medications or nicotine products. Individuals with an extreme chronotype (< 31 or > 69 on the Horne-Östberg questionnaire) or Pittsburgh Sleep Quality Index score of greater than 7 were excluded (mean ± SD = 3.5 ± 1.6). Subjects were ineligible if they had a history of shift work or if they travelled across time zones within 3 weeks prior to the start of the study. For at least 1 week before being admitted to the CSL, participants were required to maintain a fixed sleep-wake cycle of their choice (8 hours sleep, 16 hours wake), which was verified by actigraphy monitoring (Actiwatch-L, MiniMitter, Inc., Bend, OR). During prestudy screening, subjects were asked to avoid caffeine, alcohol, and over-the-counter medications. Informed consent was obtained from all participants, and research procedures were approved by the SingHealth Centralized Institutional Review Board. Procedures were in compliance with the Health Insurance Portability and Accountability Act regulations and the Declaration of Helsinki.
Protocol
Subjects lived individually for 4 days at the CSL in a soundattenuated and windowless environment that was shielded from external time cues. Participants arrived in the evening and went to bed at their regular prestudy sleep time. After an 8-hour sleep opportunity, subjects underwent a 40-hour constant routine (CR) procedure consisting of wakefulness enforced by research staff, semi-recumbent position in bed, and consumption of hourly equicaloric snacks. 15 Ambient light was provided by ceiling-mounted light-emitting diode lamps that were dimmed to less than 5 lux (1.9 μW/cm 2 ). Illuminance was measured at a height of 187 cm with an ILT1400 radiometer that was fitted with an SEL-033/ Y/W detector (International Light Technologies, Inc., Peabody, MA) aimed directly at the ceiling lamps. Illuminance measured Heart Rate Variability Correlates with Vigilance-Chua et al
Data Analysis and Statistics
Correlation between PVT lapses and physiologic measures
We performed Pearson correlation analysis to determine the strength of the linear relationship between PVT lapses and each physiologic measure. After applying a z-transformation to normalize PVT performance and physiologic data within subjects, we determined the Pearson correlation coefficient (r) in each participant and then averaged between subjects. We also performed group correlation analyses, in which data from all subjects were combined prior to determining the Pearson correlation coefficient. Since all analyses were performed using normalized data, the group correlation coefficient for any given pairwise comparison was identical to the average of individual r values. Within subjects, statistical comparisons between r values for different physiologic measures vs PVT lapses were performed using the method described by Steiger, in which a Z statistic is calculated. 24 The critical significance level was corrected for multiple comparisons using the Bonferroni correction (0.05 / n).
Receiver operating characteristic analysis
Receiver operating characteristic (ROC) analysis was used to compare the relative performance of PERCLOS, RR-interval PSD (0.02-0.08 Hz), frontal EEG PSD (1.0-4.5 Hz), and subjective sleepiness (VAS) at predicting an increase in PVT lapses above threshold. 25 The binary classification task was to identify a threshold increase (> 25%, > 50%, or > 75%) in the number of PVT lapses, measured relative to each subject's performance during baseline (see below). These arbitrary thresholds were chosen to span different degrees of performance impairment. In most individuals, PVT lapses exceeded the 25% threshold within 2 hours after habitual bedtime; at this threshold, participants began to show an unambiguous decline in PVT performance and an increase in subjective sleepiness. Thereafter, PVT lapses increased monotonically and, in most participants, exceeded the 50% threshold during the middle of the night. The 75% threshold occurred close to habitual wake time, when most subjects were struggling to keep awake. PVT performance usually improved within the next few hours, with PVT lapses dropping below the 50% and 25% thresholds in some but not all participants. Baseline performance in individuals was determined as the median number of PVT lapses per session during the first 16 hours of wakefulness. For each subject, the range of PVT lapses was then taken as the difference of the session with the maximum number of lapses during the CR procedure and the median number of lapses during baseline. Hence, the threshold for a 25% increase in PVT lapses was computed as 0.25 times the range plus baseline.
For each physiologic measure, data were z-transformed within subjects and then pooled to construct an ROC curve. The optimal classification threshold was one that maximized the function: Sensitivity -m(1-Specificity). Specifically, a slope of the tangent to the ROC curve m was defined as where FP is false positive, FN is false negative, and p is the pretest probability. 26 Cost ratios were selected using SigmaPlot to obtain a single mastoid-referenced channel (e.g., To generate group plots, the EEG PSD in each frequency band was log transformed and averaged between subjects.
The EOG
The EOG electrodes were placed lateral to the outer canthus of each eye, with leads located slightly above (right eye) and below (left eye) the bicanthal plane. Each EOG electrode was referenced to the contralateral mastoid electrode (A1 or A2). EOG data were manually scored for eye blinks by a single scorer. For each PVT session, the middle 8-minute EOG segment was divided into 240 two-second, non-overlapping epochs. The number of epochs containing at least 1 eye blink was determined for each PVT session.
Eye-tracking
To assess PERCLOS, eye-tracking data were collected during the PVT in a subset of subjects (n = 15). Pupil diameter of the left eye was recorded at 120 Hz using an ISCAN eyetracker (ISCAN, Inc., Woburn, MA). PERCLOS was defined as the percentage of time that the pupil was at least 80% covered by the eyelid. 8 Given that PERCLOS assesses slow eyelid closures, rather than blinks, we excluded eye-closure events shorter than 400 ms; this threshold for eye-blink duration falls within the range recommended for determining PERCLOS (300 to 500 ms).
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Core body temperature
Core body temperature was collected wirelessly using an ingestible VitalSense temperature transmitter (Minimitter, Inc., Bend, OR). Subjects swallowed the telemetric sensor just prior to bedtime on the first day of the study. Core temperature was transmitted to a VitalSense Integrated Physiologic Monitor placed near the subject. Five subjects who passed the sensor during the CR procedure were given a second telemetry transmitter, and data from 3 subjects were lost due to equipment failure. Temperature data were collected every minute and averaged during each PVT session.
11 software (ROC Curves Module; Systat Software Inc., San Jose, CA) and were set at 1.0, 0.5, and 0.25 for 25%, 50%, and 75% PVT lapse thresholds. Pretest probability was estimated empirically from the data, giving p equal to 0.41 for a greater than 25% increase in PVT lapses, p equal to 0.25 for a greater than 50% increase in PVT lapses, and p equal to 0.13 for a greater than 75% increase in PVT lapses.
To assess the relative performance of different physiologic measures at classifying whether a subject had performance above threshold vs performance below threshold on the PVT, we compared the area under ROC curves (AUC) using a nonparametric approach, as previously described. 25, 27 The χ 2 statistic and associated P value for pairwise AUC comparisons were determined using SigmaPlot 11 software.
RESULTS
Time Course of PVT Performance and Physiologic Measures
Subjects were kept awake continuously for 40 hours, during which they completed a 10-minute PVT every 2 hours to assess their ability to sustain visual attention ( Figure 1A ). During the usual hours of sleep, RT and the number of PVT lapses per session (RT > 0.5 s) increased sharply, reaching their highest levels at about 24 hours after wake ( Figure 1B and Figure S1A ). Thereafter, PVT performance improved but did not recover fully to baseline levels when subjects were rested (i.e., performance during the first 16 h of wake). This partial improvement in PVT performance after 24 hours of wakefulness was presumably due to increased circadian drive for alertness, which closely tracks the circadian rhythm of body temperature ( Figure S1B ). 22 The profile of subjective sleepiness was similar to that observed for PVT lapses (r = 0.59 ± 0.04, P < 0.001), with highest levels of sleepiness reported between 20 and 26 hours after wake time ( Figure 1C and Figure S1C ).
To determine whether HRV can be used to track changes in PVT performance during sleep deprivation, we examined the RR-interval time series during each PVT session (Figure 2A-B) . Heart rate (i.e., 60 divided by the average of RR intervals) showed a strong circadian rhythm similar to the body-temperature profile, whereas the standard deviation of RR intervals (SDNN) showed a time course that more closely resembled the profile for PVT lapses ( Figure S2 ). Next, we examined conventional HRV spectral analysis metrics, including spectral power in VLF, LF, and HF bands of the RR-interval time series. The profiles of VLF spectral power and PVT lapses were similar, suggesting that some measures of RR-interval PSD track a person's ability to sustain visual attention ( Figure  S2 ). To examine this possibility in greater detail, we assessed the time course of RR-interval PSD in 0.02-Hz bins from 0.0 to 0.4 Hz. PSD in the 0.02-to 0.08-Hz frequency range, which spans the upper part of the VLF band and the lower part of the LF band, correlated most strongly with PVT lapses (r = 0.68 ± 0.03, P < 0.001; Table 1 and Figure 2C ). In this frequency range, the correlation coefficient (r ) for RR-interval PSD versus PVT lapses was significantly greater than the r value for either VLF or LF PSD vs PVT lapses (Z = 4.66, P < 0.001; Z = 5.66, P < 0.001). Similar to the profile for PVT lapses, RR-interval PSD in the 0.02-to 0.08-Hz frequency range increased during the habitual hours of sleep and then showed PSD, delta activity was relatively stable during the first 16 hours of wakefulness, followed by a sharp increase during the usual hours of sleep. After a peak in delta activity 22 to 26 hours after wake, delta power decreased but remained higher than levels measured 24 hours earlier at the same relative clock times ( Figure 2F ). By comparison, theta (4.5-8.5 Hz) activity increased during the night but remained elevated after 24 hours of wake, alpha power (8.5-12.5 Hz) was lowest during the usual hours of sleep, and power in the beta band increased monotonically shortly after habitual bedtime ( Figure S4 ). PERCLOS correlated positively with PVT performance (r = 0.77 ± 0.04, P < 0.001), whereas eye blinks showed an inverted profile relative to PVT lapses (r = -0.51 ± 0.07, P < 0.001; Figure 2G-H) . Hence, as PVT performance became increasingly impaired from 16 to 24 hours after wake, subjects blinked less frequently, but the percentage of time that their eyes were closed increased. 22 Of all physiologic measures examined, PERCLOS correlated most strongly with PVT lapses (Table 1) , with an r value that was significantly greater than that observed for RR-interval PSD (0.02-0.08 Hz), frontal EEG delta power, and self-rated sleepiness (Z > 3.28 and P < 0.001 for all pairwise comparisons).
ROC Curves for Estimating PVT Lapses
To compare the relative performance of HRV at predicting an increase in PVT lapses vs other measures of sleepiness, we constructed ROC curves for RR-interval PSD (0.02-0.08 Hz), frontal EEG PSD (1.0-4.5 Hz), PERCLOS, and self-reported sleepiness (Table 2 and Figure 3A ). For each PVT session, the binary classification task was to determine whether a subject would show a greater than 25% increase in lapses from baseline, measured relative to each individual's range of PVT performance during 40 hours of wakefulness.
ROC curves for RR-interval PSD (0.02-0.08 Hz) and PERCLOS were similar, with mean AUC values of 0.87 ± 0.02 and 0.89 ± 0.02, respectively (χ 2 = 0.56, P = 0.45; Table 2 ). At their respective optimal thresholds, RR-interval PSD classified subject performance with 76% sensitivity and 89% specificity, and PERCLOS classified subject performance with 78% sensitivity and 88% specificity. By comparison, self-reported sleepiness and frontal EEG delta power performed worse at determining a greater than 25% increase in PVT lapses; AUC values for these measures were 0.83 ± 0.02 and 0.82 ± 0.02, respectively (Table 2) .
To address the possibility that the relative performance of RR-interval PSD at classifying subject performance would change at different thresholds for PVT lapses, we also compared AUC for greater than 50% and greater than 75% increases in PVT lapses (Table 2) . Across different thresholds, RR-interval PSD provided the closest performance relative to PERCLOS at correctly identifying an increase in the number of PVT lapspartial recovery toward the baseline rested state after 24 hours of wakefulness ( Figure 2D) .
Next, we compared our findings for HRV with validated measures of sleepiness derived from EEG PSD and ocular measures (Table 1) . We examined EEG PSD in 0.5-Hz bins from 0.5 to 16 Hz (Fz, Cz, Pz, and Oz; Figure 2E and Figure S3 ). The EEG frequency band that correlated most strongly with PVT lapses was delta (1.0-4.5 Hz) measured from the frontal derivation (r = 0.65 ± 0.04, P < 0.001). Although the correlation coefficient for RR-interval PSD (0.02-0.08 Hz) vs PVT lapses was higher than that observed for frontal EEG delta power (0.68 and 0.65, respectively), the difference in r values was not significant (Z = 1.05, P = 0.29). Similar to PVT lapses and RR-interval results indicate that it is possible to estimate whether a subject will show an increase in PVT lapses above threshold by comparing his RR-interval PSD (0.02-0.08 Hz) at any point in time with his RR-interval PSD when he is well rested.
DISCUSSION
Our results demonstrate that HRV can be used to estimate sleepiness-related lapses in psychomotor vigilance. During 40 hours of sustained wakefulness, RR-interval PSD in the 0.02-to 0.08-Hz range performed nearly as well as PERCLOS at classifying subject performance on the PVT. These laboratory findings suggest that ECG-derived measures could potentially be used to assess an individual's sleepiness level, similar to existing technologies that derive fatigue or sleepiness estimates from ocular measures or the EEG.
Estimating Performance Using ECG-Derived Measures
In humans, sleepiness is regulated by the interaction of homeostatic and circadian processes. 28 Hence, physiologic signals that are used to estimate sleepiness-related decrements in performance should be sensitive to homeostatic and circadian modulation. Similar to the profile of PVT lapses, we found that RR-interval PSD (0.02-0.08 Hz) increased monotonically during the usual hours of sleep, as subjects became increasingly sleep deprived. After about 24 hours of sustained wakefulness, however, RR-interval PSD and PVT lapses decreased, as the circadian rhythm of alertness opposed the build-up of homeostatic sleep pressure. These results indicate that RR-interval PSD tracks changes in PVT performance induced by interaction of the homeostatic drive to sleep and the es. PERCLOS outperformed RR-interval PSD at the 50% threshold (χ 2 = 6.71, P = 0.01), but not at the 75% threshold for PVT lapses (χ 2 = 2.58, P = 0.11). By comparison, PERCLOS outperformed EEG PSD and self-rated sleepiness at all thresholds tested (χ 2 > 7.3 and P < 0.01 for all pairwise comparisons).
Given that PERCLOS was measured in a subset of participants, we also compared AUC only in subjects in whom eye-tracking data were collected (n = 14 without any missing data). Consistent with our findings in the larger group, PERCLOS performed better than RR-interval PSD at the 50% threshold (χ 2 = 6.18, P = 0.01) but not at the 25% or 75% thresholds for PVT lapses (χ 2 = 1.70, P = 0.19; χ 2 = 2.79, P = 0.10; Table S1 ). PERCLOS outperformed frontal EEG delta power at all thresholds tested (χ 2 ≥ 6.03 and P ≤ 0.01), in addition to self-reported sleepiness at 50% and 75% thresholds for PVT lapses (χ 2 ≥ 8.20 and P < 0.01). At the 25% threshold, however, the difference in AUC for PERCLOS vs self-rated sleepiness did not reach statistical significance (χ 2 = 3.00 and P = 0.08).
In the analyses described above, physiologic measures that were collected during sleep deprivation were z-transformed within subjects prior to ROC analysis. In a real-world setting, a person's physiologic response to sleep deprivation would not be known in advance; hence, it would be necessary to estimate a person's normalization parameters using only his physiologic data at baseline. We therefore tested our HRV-based approach for estimating subject performance using leave-1-subject-out cross-validation to z-transform each individual's RR-interval PSD data. In the training group, the normalization parameters μ and σ were regressed linearly on mean and standard deviation of RR-interval PSD (0.02-0.08 Hz) measured during the first 16 hours of wakefulness. The resulting curves were then used to estimate μ and σ in each test subject, based on his RR-interval PSD measured during baseline. Transformed data were then pooled across subjects to generate ROC curves ( Figure 3B ). At the optimal classification threshold, RR-interval PSD in the 0.02-to 0.08-Hz range classified a greater than 25% increase in PVT lapses with 81% sensitivity and 85% specificity. By comparing AUC of ROC curves, we found that RR-interval PSD and PERCLOS performed equally well at identifying a greater than 25% increase in PVT lapses relative to baseline (χ 2 = 1.07, P = 0.30; Figure 3C ). AUC was also similar for RR-interval PSD vs PERCLOS at 50% and 75% PVT performance thresholds (χ 2 = 1.07, P = 0.30; χ 2 = 1.07, P = 0.30; Figure 3C ). These circadian sleep-wake cycle. Our findings also extend those by Chua et al., in which it was shown that some measures of HRV correlate with PVT performance during the daytime, in the absence of sleep deprivation. 14 We found that RR-interval PSD in the 0.02-to 0.08-Hz range correlated more strongly with PVT lapses compared to PSD in the VLF and LF bands (≤ 0.04 Hz and 0.04 to 0.15 Hz, respectively). 21 Our findings for heart rate, its overall variability, and PSD in the VLF, LF, and HF bands are consistent, however, with previous reports using similar methodology. [29] [30] [31] For example, the time course for PSD in the HF band, which is thought to reflect vagal activity, showed strong circadian variation during the first 24 hours of sustained wakefulness. [31] [32] [33] By examining HRV over a longer CR procedure than in previous studies, however, we show that HF power was much lower during the second day of sleep deprivation compared with HF power measured 24 hours earlier at the same relative clock times. Additionally, normalized LF power and the LF/HF power ratio remained elevated beyond 24 hours of continuous wakefulness, with little or no recovery toward the baseline rested state. 34 These findings are consistent with previous reports that sleep deprivation increases sympathetic tone. [34] [35] [36] Taken together, our results demonstrate that various measures of HRV are differentially sensitive to the effects of total sleep deprivation. By examining PSD of the RR-interval time series across different frequency bands, we found that power in the 0.02-to 0.08-Hz range tracked PVT performance closely during sleep deprivation, suggesting that this measure of HRV could potentially be used to predict sleepiness-related decrements in psychomotor vigilance.
Technical Considerations
The primary behavioral outcome in our study was PVT lapses, which is a measure of sustained visual attention. The PVT has been used extensively to assess the effects of sleep deprivation, 22 sleep restriction, 6 and sleep-disordered breathing 37 on vigilance levels. We did not, however, test whether sleepinessrelated decrements in other cognitive functions can be estimated by RR-interval PSD, PERCLOS, or EEG PSD.
Similar to other studies, we observed large interindividual differences in PVT performance during sleep deprivation. 38 Based on cumulative distribution plots for PVT lapses per session ( Figure S5 ), 5 lapses represented roughly the 10 th percentile of performance in some participants, corresponding to low levels of sleepiness during the first 16 hours of wakefulness. In other subjects, the same number of lapses corresponded to the 80 th percentile of performance, when subjects were sleep deprived and fighting the urge to fall asleep. To account for these interindividual differences, we used a relative threshold for defining performance that was based on each person's range of PVT lapses during sustained wakefulness. A drawback of this approach is that our model does not predict absolute performance levels. Rather, our method addresses the question: How much worse is this person's performance right now, relative to his normal 'rested' performance level? As such, our approach requires individualized calibration with a baseline measure of RR-interval PSD when the subject is not deprived of sleep. This could prove difficult in a real-world setting, as many individuals are chronically sleep deprived. Additionally, for our appropriately time breaks, naps, or pharmacologic interventions to reduce sleepiness levels.
In conclusion, our findings demonstrate that HRV can be used to estimate decrements in PVT performance resulting from total sleep deprivation. In a laboratory setting, RR-interval PSD in the 0.02-to 0.08-Hz frequency range performed nearly as well as PERCLOS at identifying a relative increase in PVT lapses caused by sleepiness. In future studies, it will be important to test whether our findings can be translated to a real-world environment. Given that ECG acquisition is minimally intrusive and potentially does not require contact with the body, our results suggest that HRV measures could be incorporated into fatigue-monitoring systems in diverse operational settings. approach to work, the user's RR-interval PSD would need to be z-transformed using normalization parameters derived from population data; such data would need to be collected prospectively in field studies.
For our laboratory findings to translate to a real-world setting, it will be important to demonstrate that RR-interval PSD can be used to predict lapses when other factors that can modulate HRV are present. For example, changes in HRV occur in cardiovascular disease 21 and in response to some medications 21 and may vary by sex and age. 39, 40 Also, it is possible that changes in posture or activity may affect RR-interval PSD in the 0.02-to 0.08-Hz frequency range. Given that we studied only young healthy men in a highly controlled laboratory environment, more studies are required to determine the influence of sex, age, health status, and activity on the relationship between HRV and sleepiness. To reduce variability in HRV in a field setting, it may be necessary to collect a person's HRV data under a standardized set of conditions or during a task in which changes in posture and activity are minimized.
Potential Applications of HRV in Fatigue Monitoring and Detection
Our laboratory results suggest that HRV deserves further evaluation as a potential indicator of sleepiness. A significant advantage of HRV over most other bio-signals is that portable and nonintrusive technologies already exist for long-term physiologic monitoring of the ECG. Telemetric cardiac monitoring has been used clinically for 50 years, and methods for collecting RR-interval data have matured substantially, with the first generation of noncontact heart rate monitors now available. 13 Current approaches for assessing a person's level of sleepiness include ocular, EEG, and video-based monitoring. Consistent with a previous study that compared different fatigue-monitoring technologies, 8 we found that PERCLOS outperformed EEG and eye-blink measures at estimating PVT performance. By comparison, RR-interval PSD and PERCLOS classified PVT performance with similar sensitivity and specificity. Given that PERCLOS associates reliably with lapses in attention and driving performance, 8 in future studies it will be important to test whether RR-interval PSD can also be used to predict drowsiness-related lapses in simulated driving performance. Also, because we examined HRV only during total sleep deprivation, in future studies, it will be important to test whether RR-interval PSD can be used to estimate sleepinessrelated decrements in performance during chronic sleep restriction or acute partial sleep loss.
In the present study, we did not examine whether HRV measures can be used to assess sleepiness on a moment-tomoment basis. It is possible that a person could temporarily increase his alertness level or RR-interval PSD in the 0.02-to 0.08-Hz frequency range by performing a stimulating activity (e.g., by singing aloud to music, exercising, or pinching himself). Such strategies are sometimes employed by drowsy drivers in an attempt to override the urge to fall asleep at the wheel. Although ocular measures, EEG, or video-based monitoring systems may outperform HRV metrics in detecting when an operator has fallen sleep, our results nonetheless suggest that HRV measures could potentially be used to track an individual's overall sleepiness level during tasks that require sustained visual attention. Such information could be used to Mean log RT (ms) Table S1 -Relative performance of different physiologic measures at identifying an increase in PVT lapses above threshold (Sub-group analysis for subjects with PERCLOS measurements and no missing data for other physiological measurements; n = 14). Physiologic measures are ranked by area under the curve (AUC) of receiver operating characteristic (ROC) curves in descending order of magnitude at different PVT lapse thresholds. Sensitivity and specificity values were determined at the optimal classification threshold, with 95% confidence intervals shown in parentheses. At each PVT lapse threshold tested, the AUC of ROC curves for RR-interval PSD (0.02-0.08 Hz), self-reported sleepiness (visualanalog scale [VAS]), and electroencephalographic (EEG) delta power were compared to the AUC for percentage of eyelid closure over the pupil over time (PERCLOS). For each pairwise comparison, the χ 2 statistic is shown in the far right column.
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